Search research articles
Contact Us
Filters
Showing results (1-10 of 250) with videos related to
Page
of 25
Sort By:
Innere Medizin (Heidelberg, Germany)
|
January 16, 2023
[Parkinson's disease and Alzheimer type dementia-Pathophysiology and drug treatment approaches]
Richard Dodel
Expert Review of Neurotherapeutics
|
August 12, 2025
Donanemab for Alzheimer's disease: from preclinical research to the clinical application
Richard Dodel, Lutz Frölich
Advances in Experimental Medicine and Biology
|
August 21, 2012
Naturally occurring autoantibodies against β-Amyloid
Jan-Philipp Bach, Richard Dodel
Molecular Diagnosis & Therapy
|
June 1, 2011
Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential
Carmen Noelker, Harald Hampel, Richard Dodel
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
August 2, 2006
[Cost and quality aspects in the treatment of Parkinson's disease]
Thomas Müller, Richard Dodel, Jürgen Fritze
Expert Opinion on Biological Therapy
|
January 26, 2011
Antibody-based therapy in Alzheimer's disease
Refik Pul, Richard Dodel, Martin Stangel
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
July 20, 2011
[Benchmarking in patient care: depression in Parkinson's disease]
Annika Spottke, Frank Schneider, Richard Dodel
Progress in Neurobiology
|
October 11, 2011
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Claire Henchcliffe, Richard Dodel, M Flint Beal
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 13, 2009
Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review
Maren Elisabeth Bodden, Richard Dodel, Elke Kalbe
Clinical Chemistry
|
May 25, 2026
Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues
Melissa Ix, Richard Dodel, J Alexander Ross
Page
of 25
Search research articles
Search
Showing results (1-10 of 250) with videos related to
Sort By:
Page
of 25
Innere Medizin (Heidelberg, Germany)
|
January 16, 2023
[Parkinson's disease and Alzheimer type dementia-Pathophysiology and drug treatment approaches]
Richard Dodel
Expert Review of Neurotherapeutics
|
August 12, 2025
Donanemab for Alzheimer's disease: from preclinical research to the clinical application
Richard Dodel, Lutz Frölich
Advances in Experimental Medicine and Biology
|
August 21, 2012
Naturally occurring autoantibodies against β-Amyloid
Jan-Philipp Bach, Richard Dodel
Molecular Diagnosis & Therapy
|
June 1, 2011
Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential
Carmen Noelker, Harald Hampel, Richard Dodel
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
August 2, 2006
[Cost and quality aspects in the treatment of Parkinson's disease]
Thomas Müller, Richard Dodel, Jürgen Fritze
Expert Opinion on Biological Therapy
|
January 26, 2011
Antibody-based therapy in Alzheimer's disease
Refik Pul, Richard Dodel, Martin Stangel
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
July 20, 2011
[Benchmarking in patient care: depression in Parkinson's disease]
Annika Spottke, Frank Schneider, Richard Dodel
Progress in Neurobiology
|
October 11, 2011
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Claire Henchcliffe, Richard Dodel, M Flint Beal
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 13, 2009
Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review
Maren Elisabeth Bodden, Richard Dodel, Elke Kalbe
Clinical Chemistry
|
May 25, 2026
Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues
Melissa Ix, Richard Dodel, J Alexander Ross
Page
of 25